search button
Open Access

Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo

  • Authors:
    • Jian Wang
    • Cunfu Liang
    • Fansheng Meng
    • Xiangwen Xu
    • Yan Wu
    • Lin Lu

  • View Affiliations

  • Published online on: June 28, 2019     https://doi.org/10.3892/ol.2019.10543
  • Pages: 2286-2291

  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epstein‑Barr virus nuclear antigen 1 (EBNA1) is associated with the pathogenesis of Epstein‑Barr virus‑associated gastric carcinoma (EBVaGC). However, the function of EBNA1 in the growth of EBVaGC cells remains unclear. In the present study, the effects of silencing EBNA1, by RNA interference (RNAi), on the growth of EBVaGC cells were investigated in vitro and in vivo. A lentivirus‑mediated RNAi targeting EBNA1 was transfected into the EBVaGC cell line GT‑38. Reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), western blot analysis, MTT, colony formation and flow cytometry were performed to evaluate the biological behavior of GT‑38 cells that were transfected with EBNA1 small interfering RNA (siRNA) in vitro. The effects of silencing EBNA1 on tumor growth were assessed in a tumor xenograft model using BALB/c nude mice. The results demonstrated that the proliferative and clonogenic abilities of GT‑38 cells were significantly downregulated in response to EBNA1 siRNA (P<0.01). Furthermore, EBNA1 siRNA induced cell cycle arrest in the G0/G1 phase and promoted apoptosis of GT‑38 cells (P<0.01). The tumorigenicity of GT‑38 cells was significantly inhibited in the EBNA1 siRNA group. The results revealed that lentivirus‑mediated RNAi of EBNA1 inhibited the growth of the EBVaGC cell line GT‑38 in vitro and in vivo. Therefore, EBNA1 may be a potential target for gene therapy in EBVaGC.
View Figures
View References

Related Articles

Journal Cover

September-2019
Volume 18 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.9
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 6.3
  • CiteScore Rank: Q2: #119/366 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.725
  • SCImago Journal Rank (SJR): 0.639
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Liang C, Meng F, Xu X, Wu Y and Lu L: Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo. Oncol Lett 18: 2286-2291, 2019
APA
Wang, J., Liang, C., Meng, F., Xu, X., Wu, Y., & Lu, L. (2019). Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo. Oncology Letters, 18, 2286-2291. https://doi.org/10.3892/ol.2019.10543
MLA
Wang, J., Liang, C., Meng, F., Xu, X., Wu, Y., Lu, L."Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo". Oncology Letters 18.3 (2019): 2286-2291.
Chicago
Wang, J., Liang, C., Meng, F., Xu, X., Wu, Y., Lu, L."Lentivirus‑mediated RNA interference targeting EBNA1 gene inhibits the growth of GT‑38 cells in vitro and in vivo". Oncology Letters 18, no. 3 (2019): 2286-2291. https://doi.org/10.3892/ol.2019.10543